Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blase Polite

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|December 16, 2019
Race and Gender Differences in Awareness of Colorectal Cancer Screening Tests and Guidelines Among Recently Diagnosed Colon Cancer Patients in an Urban SettingLeslie R Carnahan, Lindsey Jones, Katherine C Brewer, et al.
JCO Oncology Practice|July 13, 2021
Oncology Medical Home: ASCO and COA StandardsKim Woofter, Erin B Kennedy, Kerin Adelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2014
Phase I dose-escalation study of onartuzumab as a single agent and in combination with bevacizumab in patients with advanced solid malignanciesRavi Salgia, Premal Patel, John Bothos, et al.
Clinical Colorectal Cancer|April 23, 2024
Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and EEric X Chen, Petr Kavan, Mustapha Tehfe, et al.
JCO Oncology Practice|July 21, 2025
Oncology Medical Homes: ASCO-Community Oncology Alliance StandardsKim Woofter, Erin B Kennedy, Kerin Adelson, et al.
The American Journal of Hospice & Palliative Care|March 5, 2021
Improving End of Life Cancer Outcomes Through Development and Implementation of a Spiritual Care Advocate ProgramToni Cipriano-Steffens, John F Cursio, Fay Hlubocky, et al.
JAMA Network Open|November 7, 2023
Early Integrated Palliative Care Within a Surgical Oncology ClinicVarun V Bansal, Daniel Kim, Biren Reddy, et al.
Pharmacogenetics and Genomics|December 15, 2015
Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)Adam M Lee, Qian Shi, Steven R Alberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2026
NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal CanalVan K Morris, Kristen K Ciombor, Lianchun Xiao, et al.
Annals of Surgical Oncology|January 6, 2022
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) LevelsAnkit Dhiman, Charles C Vining, Hunter D D Witmer, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|December 16, 2019
Race and Gender Differences in Awareness of Colorectal Cancer Screening Tests and Guidelines Among Recently Diagnosed Colon Cancer Patients in an Urban SettingLeslie R Carnahan, Lindsey Jones, Katherine C Brewer, et al.
JCO Oncology Practice|July 13, 2021
Oncology Medical Home: ASCO and COA StandardsKim Woofter, Erin B Kennedy, Kerin Adelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2014
Phase I dose-escalation study of onartuzumab as a single agent and in combination with bevacizumab in patients with advanced solid malignanciesRavi Salgia, Premal Patel, John Bothos, et al.
Clinical Colorectal Cancer|April 23, 2024
Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and EEric X Chen, Petr Kavan, Mustapha Tehfe, et al.
JCO Oncology Practice|July 21, 2025
Oncology Medical Homes: ASCO-Community Oncology Alliance StandardsKim Woofter, Erin B Kennedy, Kerin Adelson, et al.
The American Journal of Hospice & Palliative Care|March 5, 2021
Improving End of Life Cancer Outcomes Through Development and Implementation of a Spiritual Care Advocate ProgramToni Cipriano-Steffens, John F Cursio, Fay Hlubocky, et al.
JAMA Network Open|November 7, 2023
Early Integrated Palliative Care Within a Surgical Oncology ClinicVarun V Bansal, Daniel Kim, Biren Reddy, et al.
Pharmacogenetics and Genomics|December 15, 2015
Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)Adam M Lee, Qian Shi, Steven R Alberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2026
NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal CanalVan K Morris, Kristen K Ciombor, Lianchun Xiao, et al.
Annals of Surgical Oncology|January 6, 2022
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) LevelsAnkit Dhiman, Charles C Vining, Hunter D D Witmer, et al.
Pageof 5